Main menu

London Calling 2023: Nanopore sequencing of ctDNA — better than short read!

Get startedSubscribe
Return to Resources

In this talk I will discuss the potential applications of nanopore ctDNA sequencing in developing a pan-cancer assay for detection and screening. Through this, I will demonstrate data that shows the detection of MDM2 copy number in sarcoma samples as well as very low input VAF samples. I will also give an overview of some of the technical challenges that have to be overcome with nanopore sequencing of ctDNA

Authors: Andrew Beggs
Learn more about cancer research and sequencing
  • Published on: May 19 2023

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

© 2008 - 2023 Oxford Nanopore Technologies plc. All rights reserved. 登記された事務所：Gosling Building,\n Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK {'|'} 登記番号：05386273 {'|'} VAT番号：336942382。Oxford\n Nanopore Technologies、Wheel icon、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、\n PromethION、SmidgION、UbikおよびVolTRAXは様々な国で登録されたOxford Nanopore Technologies\nの商標です。Oxford Nanopore Technologies製品は、\n現在すべて研究用です。

Japanese flag